Public beta© 2026 Adaptrex, LLC
Public beta© 2026 Adaptrex, LLC
Federal grant · project grant (b)
The Role of Inflammation in Regulating Gastric Metaplasia - Abstract the Knowledge Gaps This Application Addresses Are How Precancerous Lesions (i.e. Metaplasia) Arise and Subsequently Fuel Adenocarcinoma of the Stomach. Infection With Helicobacter Pylori (H. Pylori) and Autoimmune Gastritis Both Cause Chronic Inflammation and Increase the Risk of Gastric Cancer. This Application Includes Numerous Mouse Models and Human Tissue Samples to Investigate the Importance of Immune Cells (mast Cells and TH2 T Cells) and Cytokines (IL4 and IL13) in Inducing Gastric Metaplasia and Promoting the Development of Gastric Metaplasia and Tumorigenesis. Identifying Inflammatory Cells and Signals That Initiate Metaplasia and Drive Tumor Development Could Improve the Ability to Identify Individuals at an Increased Risk of Disease Progression, and New Immune Based Strategies to Prevent and Treat Preneoplastic Lesions Associated With Gastric Diseases, Including Gastric Cancer.
Committed
$2.1 Million
Paid out
$1.6M
75%
Committed, not yet paid
$537.2K
25%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…